Genetic Breast Cancer Test Approved
56445
WEDNESDAY, Jan. 16 (HealthDay News) -- A new genetic test that helps assess the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer has been approved by the U.S. Food and Drug Administration.
28501
A blood test has been developed which counts cancer cells in the advanced breast cancer patientâs blood stream and tells whether the treatment is successful.
244809
Magnetic resonance imaging (MRI) may be the best screening tool for breast cancer in women who carry the genetic mutation that makes them susceptible to the disease, according to new research.
77031
U.S. health officials have approved a Gen-Probe Inc. test to help diagnose the HIV virus sooner, the Food and Drug Administration said on Thursday.
255929
WASHINGTON -- Doctors can check patients&#39; DNA when choosing medication for them, using a test the Food and Drug Administration said Thursday it has approved.
538265
U.S. regulators cleared a new  genetic test on Monday that helps predict tumor recurrence and  long-term survival in breast cancer patients with higher risk  of the cancer returning.
399257
WASHINGTON - U.S. health officials approved a genetic test on Tuesday that can give women with early breast cancer an estimate of whether the disease is likely to return in five to 10 years.
146576
A genetic profiling test already on the market accurately predicts which breast cancer patients will benefit from chemotherapy and which won't, giving women a powerful tool to help decide whether to undergo the ordeal, scientists report.
52884
SAN ANTONIO -- A genetic profiling test already on the market accurately predicts which breast cancer patients will benefit from chemotherapy and which won&#39;t, giving women a powerful tool to help decide whether to undergo the ordeal, scientists report.
94193
Researchers from Canada believe they have identified the gene responsible for breast cancer tumor growth, a discovery that could possibly lead to a cure for the disease.
563005
U.S. News & World Report - Male relatives of breast-cancer patients might want to be tested
36374
The FDA has approved the drug letrozole for use in postmenopausal women with early breast cancer who have completed standard adjuvant tamoxifen therapy.
320785
The results of studies released today show a new blood test holds promise for improving the treatment of advanced breast cancer.
159339
A new test developed in the Bay Area could make a huge difference for women diagnosed with a common form of breast cancer. Each year, roughly 50,000 women are diagnosed with early-stage, estrogen-dependent breast cancer.
306171
Women with early stage breast cancer may soon get another gene test to help predict whether they'll relapse in five or 10 years, information that could influence how aggressively they fight the initial tumor.
185930
U.S. regulators cleared a new genetic test on Monday that helps predict tumor recurrence and long-term survival in breast cancer patients with higher risk of the cancer returning.
761145
Roche has received F.D.A. approval to market the first gene test that can help doctors reduce the risk of side effects for certain medications.